...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function.
【24h】

Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function.

机译:患有自身免疫性疾病的甲状腺功能正常的妇女正在接受辅助生殖技术:自身免疫性和甲状腺功能的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Thyroid dysfunction and the presence of thyroid antibodies increase the risk of infertility and miscarriage. The aim of the present study was to assess if patients with autoimmune thyroid disease undergoing assisted reproduction technologies (ART) are afflicted by poor pregnancy and/or delivery rate and if the outcome is conditioned by pre-ART thyroid status. The study was retrospective (from January 2000 to January 2005) and was carried out at the Division of Physiopathology of Human Reproduction. Women who underwent ART were tested for TSH, free T4 (FT4), thyroid peroxidase antibodies (TPOAb) before and during pregnancy. A total of 416 euthyroid women were selected; 42 (10.1%) were TPOAb (+). Women >35 yr were excluded. The endpoints were pregnancy and delivery rates. RESULTS: no differences in pregnancy and delivery rates were observed between women with and without antibodies. In TPOAb (+), women who failed to become pregnant or miscarried displayed higher TSH values before ART (2.8 mIU/l) comparedto the ones who delivered (1.6 mIU/l; p=0.032) and compared to TPOAb (-) (1.1 mIU/l; p=0.018). CONCLUSIONS: in euthyroid women undergoing ART the pregnancy and delivery rates are not affected by the presence of TPOAb. In TPOAb (+) high-normal TSH values are associated with increased risk of unsuccessful pregnancy or subsequent miscarriage. Further studies are required to ascertain possible benefits of levo-T4 (L-T4) in such patients.
机译:甲状腺功能障碍和甲状腺抗体的存在增加了不孕和流产的风险。本研究的目的是评估接受辅助生殖技术(ART)的自身免疫性甲状腺疾病患者是否受不良妊娠和/或分娩率的困扰,以及预后是否受ART前甲状腺状态的影响。这项研究是回顾性的(从2000年1月至2005年1月),并在人类生殖生理病理学部门进行。接受抗逆转录病毒治疗的妇女在怀孕前和怀孕期间接受了TSH,游离T4(FT4),甲状腺过氧化物酶抗体(TPOAb)的检测。总共选择了416名甲状腺功能正常的女性。 TPOAb(+)为42(10.1%)。年龄大于35岁的女性被排除在外。终点为妊娠和分娩率。结果:有和没有抗体的女性之间的妊娠率和分娩率没有差异。在TPOAb(+)中,未怀孕或流产的妇女与分娩(1.6 mIU / l; p = 0.032)的妇女相比,在TPOAb(-)(1.1)的情况下显示较高的TSH值(2.8 mIU / l)。 mIU / l; p = 0.018)。结论:接受抗逆转录病毒治疗的甲状腺功能正常的妇女的妊娠率和分娩率不受TPOAb的影响。在TPOAb(+)中,高TSH正常值与怀孕失败或随后流产的风险增加相关。需要进一步研究以确定左旋-T4(L-T4)在此类患者中的可能益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号